The Team

We are building on our foundational science by recruiting established and accomplished drug developers, supported by a leading executive team and leveraging the knowledge and expertise of our investors and world-renowned advisers.


Our accomplished and internationally-experienced team is focused on building a great culture, dedicated to transforming the treatment of autoimmune disease.

Eliot Charles

Executive Chair

Bob Stein

Interim CSO

Rob Boyd

Senior Director – Preclinical

Tim Funnell

VP Operations

Chris Paluch

Team Leader – Discovery

Linda Dowdell

Office Manager

Sara Moreira da Silva

Associate Scientist

Heather Brouwer

Senior Research Assistant
(Secondment from Prof Davis Laboratory)


MiroBio was founded by two leading immunologists at the University of Oxford, Professors Richard Cornall and Simon Davis. They have spent more than 15 years generating the understanding of immune-signalling mechanisms that underpins our development of new therapeutics.

Richard Cornall

Founder and Scientific Advisor

Simon Davis

Founder and Scientific Advisor


MiroBio is supported by a sophisticated syndicate of investors who provide much more than capital. Our investor Directors have deep experience in antibody development, immunology and building industry-leading companies.

Srini Akkaraju

Director - Samsara BioCapital

Debbie Harland

Director - SR One

Shahzad Malik

Director - Advent Life Sciences

Andrew McLean

Director - Oxford Sciences Innovation


MiroBio is working with internationally distinguished immunologists to guide our fundamental technology and its translation to the clinic.

Tomas Mustelin

Scientific Advisor

Jason Cyster

Scientific Advisor